Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Anxiety Disorders & Depression Treatment Market Size study, by Product (Antidepressant Drugs and Therapy & Devices), by Indication (MDD, OCD, Phobia and Others), and Regional Forecasts 2021-2027

  • BIZ4412128
  • 200 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Anxiety Disorders & Depression Treatment Market is valued approximately USD 16.66 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.85% over the forecast period 2021-2027. Anxiety and Depression are classified as a mood disorders symptoms of which include feelings of sadness, loss, or anger that interfere with a person’s everyday activities. Major Depressive Disorder, Persistent depressive disorder and Premenstrual dysphoric disorder are some commonly occurring types of depression. After the COVID-19 pandemic, there is the sudden upsurge of mental health related disorders due to the grim atmosphere around, social distancing and loneliness. The rise in cases of depression and anxiety disorders, coupled with the increasing awareness for the mental health wellbeing, are driving the Anxiety Disorders & Depression Treatment market. Depression has become a rapidly commonplace disorder, due to hectic lifestyle and stressed work and personal life. According to anxiety and depression association of America, depression is the leading cause of disability in the United States among people ages 15-44. It also reports that in 2017, an estimated 17.3 million aged 18 years or older had experienced at least one major depressive episode in the last year in USA, which represented 6.7 percent of all American adults. Almost 75% of people with mental disorders remain untreated in developing countries such as India and China, with almost 1 million people committing suicide. The patents of many companies operating in anxiety and depression treatment are expiring which are giving rise to use of generics. The issues of expiration of patents of branded anxiety and depression curing drugs may act as a restraint for its growth. However, increasing efforts of government to tackle mental health issues acts as an opportunity for Anxiety Disorders & Depression Treatment Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analyzed to provide a holistic picture of Anxiety Disorders & Depression Treatment Market. Due to increased awareness for depression and anxiety as well as higher per capita income, North America is the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing population living a stressed work and personal life.

Major market player included in this report are:

Pfizer Inc

GlaxoSmithKline

Merck & Co. Inc

AstraZeneca

Eli Lily & Co

Johnson & Johnson

Forest Laboratories, Inc

Sanofi-Aventis

H. Lundbeck A/S

Bristol-Myers Squibb Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Antidepressant Drugs

Therapy & Devices

By Indication:

Major Depressive Disorder (MDD)

Obsessive-Compulsive Disorder (OCD)

Phobia

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Anxiety Disorders & Depression Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Anxiety Disorders & Depression Treatment Market, by Product, 2019-2027 (USD Billion)

1.2.2. Anxiety Disorders & Depression Treatment Market, by Indication, 2019-2027 (USD Billion)

1.2.3. Anxiety Disorders & Depression Treatment Market, by region, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Anxiety Disorders & Depression Treatment Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Anxiety Disorders & Depression Treatment Market Dynamics

3.1. Anxiety Disorders & Depression Treatment Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing population with anxiety and depression disorders

3.1.1.2. Growing awareness for mental disorders

3.1.2. Market Challenges

3.1.2.1. Expiration of patents of depression and anxiety medications

3.1.3. Market Opportunities

3.1.3.1. Governmental initiatives to tackle mental health

Chapter 4. Global Anxiety Disorders & Depression Treatment Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Anxiety Disorders & Depression Treatment Market, by Product

5.1. Market Snapshot

5.2. Global Anxiety Disorders & Depression Treatment Market by Product, Performance - Potential Analysis

5.3. Global Anxiety Disorders & Depression Treatment Market Estimates & Forecasts by Product 2018-2027 (USD Billion)

5.4. Anxiety Disorders & Depression Treatment Market, Sub Segment Analysis

5.4.1. Antidepressant Drugs

5.4.2. Therapy & Devices

Chapter 6. Global Anxiety Disorders & Depression Treatment Market, by Indication

6.1. Market Snapshot

6.2. Global Anxiety Disorders & Depression Treatment Market by Indication, Performance - Potential Analysis

6.3. Global Anxiety Disorders & Depression Treatment Market Estimates & Forecasts by Indication 2018-2027 (USD Billion)

6.4. Anxiety Disorders & Depression Treatment Market, Sub Segment Analysis

6.4.1. Major Depressive Disorder (MDD)

6.4.2. Obsessive-Compulsive Disorder (OCD)

6.4.3. Phobia

6.4.4. Others

Chapter 7. Global Anxiety Disorders & Depression Treatment Market, Regional Analysis

7.1. Anxiety Disorders & Depression Treatment Market, Regional Market Snapshot

7.2. North America Anxiety Disorders & Depression Treatment Market

7.2.1. U.S. Anxiety Disorders & Depression Treatment Market

7.2.1.1. Product breakdown estimates & forecasts, 2018-2027

7.2.1.2. Indication breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Anxiety Disorders & Depression Treatment Market

7.3. Europe Anxiety Disorders & Depression Treatment Market Snapshot

7.3.1. U.K. Anxiety Disorders & Depression Treatment Market

7.3.2. Germany Anxiety Disorders & Depression Treatment Market

7.3.3. France Anxiety Disorders & Depression Treatment Market

7.3.4. Spain Anxiety Disorders & Depression Treatment Market

7.3.5. Italy Anxiety Disorders & Depression Treatment Market

7.3.6. Rest of Europe Anxiety Disorders & Depression Treatment Market

7.4. Asia-Pacific Anxiety Disorders & Depression Treatment Market Snapshot

7.4.1. China Anxiety Disorders & Depression Treatment Market

7.4.2. India Anxiety Disorders & Depression Treatment Market

7.4.3. Japan Anxiety Disorders & Depression Treatment Market

7.4.4. Australia Anxiety Disorders & Depression Treatment Market

7.4.5. South Korea Anxiety Disorders & Depression Treatment Market

7.4.6. Rest of Asia Pacific Anxiety Disorders & Depression Treatment Market

7.5. Latin America Anxiety Disorders & Depression Treatment Market Snapshot

7.5.1. Brazil Anxiety Disorders & Depression Treatment Market

7.5.2. Mexico Anxiety Disorders & Depression Treatment Market

7.6. Rest of The World Anxiety Disorders & Depression Treatment Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Pfizer Inc

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. GlaxoSmithKline

8.2.3. Merck & Co. Inc

8.2.4. AstraZeneca

8.2.5. Eli Lily & Co

8.2.6. Johnson & Johnson

8.2.7. Forest Laboratories, Inc

8.2.8. Sanofi-Aventis

8.2.9. H. Lundbeck A/S

8.2.10. Bristol-Myers Squibb Company

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Anxiety Disorders & Depression Treatment Market, report scope

TABLE 2. Global Anxiety Disorders & Depression Treatment Market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Anxiety Disorders & Depression Treatment Market estimates & forecasts by Product 2018-2027 (USD Billion)

TABLE 4. Global Anxiety Disorders & Depression Treatment Market estimates & forecasts by Indication 2018-2027 (USD Billion)

TABLE 5. Global Anxiety Disorders & Depression Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Anxiety Disorders & Depression Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Anxiety Disorders & Depression Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Anxiety Disorders & Depression Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Anxiety Disorders & Depression Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Anxiety Disorders & Depression Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Anxiety Disorders & Depression Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Anxiety Disorders & Depression Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Anxiety Disorders & Depression Treatment Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Anxiety Disorders & Depression Treatment Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. U.S. Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 17. U.S. Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. Canada Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Canada Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. Canada Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. UK Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. UK Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. UK Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Germany Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Germany Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Germany Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. RoE Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. RoE Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. RoE Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. China Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. China Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. China Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. India Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. India Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. India Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Japan Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Japan Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Japan Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. RoAPAC Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. RoAPAC Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. RoAPAC Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. Brazil Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. Brazil Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Brazil Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Mexico Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. Mexico Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Mexico Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. RoLA Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. RoLA Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. RoLA Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Row Anxiety Disorders & Depression Treatment Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Row Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Row Anxiety Disorders & Depression Treatment Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. List of secondary sources, used in the study of global Anxiety Disorders & Depression Treatment Market

TABLE 55. List of primary sources, used in the study of global Anxiety Disorders & Depression Treatment Market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390